<DOC>
	<DOCNO>NCT02358369</DOCNO>
	<brief_summary>The Bimatoprost Ocular Insert intend provide sustain delivery bimatoprost ocular surface lower intraocular pressure ( IOP ) patient open-angle glaucoma ocular hypertension . This study evaluate safety efficacy two different dos Bimatoprost Ocular Insert , compare active control arm timolol ophthalmic solution ( 0.5 % ) .</brief_summary>
	<brief_title>Dose-Ranging Study Bimatoprost Ocular Insert</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Key Written inform consent At least 18 year age Diagnosis eye either primary openangle glaucoma ( POAG ) ocular hypertension Best correcteddistance visual acuity score equivalent 20/80 well Stable visual field Central corneal thickness 490 620 micrometer Inclusion Criteria Randomization Visit : IOP eye ≥ 23 mmHg T=0hr , ≥ 20 mmHg T=2hr T=8hr . Intereye IOP difference ≤ 5.0 mmHg T=0hr , T=2hr T=8hr . IOP eye ≤ 30 mmHg T=0hr , T=2hr T=8hr . Key Any known contraindication prostaglandin analog ( latanoprost , travoprost , bimatoprost , tafluprost ) timolol A cardiac pulmonary condition opinion Investigator would contraindicate use betablocker drop Cuptodisc ratio great 0.8 Significant risk angle closure due pupil dilation , define Shaffer classification less Grade 2 base gonioscopy Ocular , orbital , and/or eyelid surgery type within past six ( 6 ) month screen date Laser surgery glaucoma / ocular hypertension one ( 1 ) eye within last six ( 6 ) month Past history incisional surgery glaucoma time Past history corneal refractive surgery Corneal abnormality would interfere accurate IOP reading applanation tonometer Current participation investigational drug device study participation study within 30 day Screening Inability adequately evaluate retina Subjects require contact lens use study period . Subjects currently punctal occlusion Pregnant , lactate childbearing potential use medically acceptable form birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>